ANTONIO MARÍA
CABALLERO MATEOS
Investigador en el periodo 2022-2022
Institut d'Investigació Biomèdica Girona
Girona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (14)
2021
-
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645
-
Study protocol on Socioeconomic and Geographic Inequalities in Cancer Incidence, Mortality and Survival in Spain: Multilevel Population-Base Study: DESOCANES study
Gaceta Sanitaria, Vol. 35, Núm. 2, pp. 199-203
2020
-
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159
2017
-
Cancer incidence in Spain, 2015
Clinical and Translational Oncology, Vol. 19, Núm. 7, pp. 799-825
-
Data quality in rare cancers registraton: The report of the RARECARE data quality study
Tumori, Vol. 103, Núm. 1, pp. 22-32
-
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007
Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 301-316
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353
-
Trends in net survival from kidney cancer in six European Latin countries: Results from the SUDCAN population-based study
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S121-S127
-
Trends in net survival from skin malignant melanoma in six European Latin countries: Results from the SUDCAN population-based study
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S77-S84
2015
-
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129
-
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
The Lancet, Vol. 385, Núm. 9972, pp. 977-1010
-
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230
2013
-
Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study
Gynecologic Oncology, Vol. 130, Núm. 3, pp. 609-614
-
Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project
European Journal of Cancer, Vol. 49, Núm. 11, pp. 2565-2578